Access to Medicines

The plan to revive medicines regulation in South Africa

The plan to revive medicines regulation in South Africa

SAHPRA inherited a backlog of around 16 000 medicine regulatory applications from the MCC. How can this backlog be processed and medicines ...
A healthcare system in crisis: The long road ahead

A healthcare system in crisis: The long road ahead

A Speech by Sibongile Tshabalala, TAC National Chairperson, 11 June 2019, SA AIDS Conference Opening Plenary, Durban. ...
Why SA’s medicines regulator should consider affordability

Why SA’s medicines regulator should consider affordability

Access to medicines is a complex, but critical issue. SECTION27\'s Tendai Mafuma and Nomatter Ndebele explore how the South African Health Products ...
ARV stockouts putting lives at risk, says SSP

ARV stockouts putting lives at risk, says SSP

Stockouts of several critical medicines have been reported at healthcare facilities in five provinces, according to a statement from the Stop ...
Regulatory barriers to life-saving and affordable HCV medicines can be overcome

Regulatory barriers to life-saving and affordable HCV medicines can be overcome

A new class of medicines called direct- acting antivirals have revolutionised the treatment of hepatitis C, but access in South Africa remains ...
Donor shift threatens adherence clubs in the Free State

Donor shift threatens adherence clubs in the Free State

A shift in donor funding for HIV has endangered the continued existence of successful and effective antiretroviral adherence clubs in the Free State. ...
Stockout of Depo-Testosterone is life threatening

Stockout of Depo-Testosterone is life threatening

Depo-Testosterone, an affordable injectable hormone, has been out of stock in South Africa for more than three months. The shortage has been ...
System-wide neglect of the transgender population

System-wide neglect of the transgender population

The recent stock-out of a hormone used in gender-affirming treatment for transgender men has revealed a system-wide neglect of a large sector of the ...
Analysis: How a cutting edge medicine made it to SA’s new ARV tender

Analysis: How a cutting edge medicine made it to SA’s new ARV tender

New medicines usually take many years or even decades to reach public sector patients in South Africa. One new HIV medicine is an exception. ...
Dolutegravir- why new does not automatically mean better

Dolutegravir- why new does not automatically mean better

While the advantages of the new antiretroviral drug dolutegravir have been extensively reported, the potential disadvantages have received ...
Let women decide whether they want to take dolutegravir

Let women decide whether they want to take dolutegravir

An important new antiretroviral medicine will soon become available to people living with HIV in various Sub-Saharan African countries., ...
AIDS2018: Reduction in price of bedaquiline welcome, but is it enough?

AIDS2018: Reduction in price of bedaquiline welcome, but is it enough?

This week the price of bedaquiline in the public sector in South Africa was cut in half. What does this mean for the increased uptake of this ...